UnitedHealth Group Beats Q1 2026 Expectations and Raises Full-Year Profit Outlook
UnitedHealth Group beat expectations, raised outlook, cut costs, and grew steadily—showing a solid turnaround and boosting investor confidence.
UnitedHealth Group beat expectations, raised outlook, cut costs, and grew steadily—showing a solid turnaround and boosting investor confidence.
Abbott beat Q1 earnings, boosted by cancer diagnostics deal, but cut 2026 profit outlook due to acquisition costs.
WW International reported Q4 and full-year 2025 results beating guidance, with strong growth in clinical subscribers thanks to GLP-1 integration.